This inventor holds 24 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Molecular Delivery Systems. Top assignees: Yale University, The United States Government as Represented by the Department of Veterans Affairs, Allegiance Corporation. Active years: 1980-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Anaholo, Kauai, HI (US) (1980)
- Eden Prairie, MN (US) (1987)
- Bakersfield, CA (US) (1982 - 1999)
- Richland, WA (US) (2000)
- Watervliet, NY (US) (2000)
- New Boston, NH (US) (2010 - 2016)
- Branford, CT (US) (2017)
- Guilford, CT (US) (2017 - 2023)
Company Filing History:
9 out of 1,365 
6 out of 957 
2 out of 205 
Years Active: 1980-2026
Areas of Expertise:
Title: Innovations of James E. Hansen in Biotechnology
Introduction
James E. Hansen, based in Guilford, CT, is an accomplished inventor with an impressive portfolio of 20 patents. His work primarily focuses on advancements in biotechnology, particularly in the delivery of therapeutic agents for various diseases, including cancer.
Latest Patents
Among Hansen's latest patents is a groundbreaking technology involving cell-penetrating anti-DNA binding proteins. This patented development relates to compositions that may facilitate the delivery of agents to cells, offering potential treatments for diseases such as cancer. Another notable invention is the antibody-mediated autocatalytic, targeted delivery of nanocarriers to tumors. This patent presents DNA-targeted nanocarriers capable of encapsulating active agents and delivering them to extracellular DNA. These nanocarriers, which may be polymeric particles, liposomes, or multilamellar vesicles, are equipped with targeting moieties that specifically bind to DNA. In certain embodiments, these targeting moieties include antibody 3E10 or its variants, fragments, or fusion proteins, enhancing the efficacy of drug delivery to tumor sites.
Career Highlights
Hansen's professional journey includes significant contributions through his tenure at prestigious institutions, including Yale University. His academic affiliations have allowed him to collaborate with a network of researchers, significantly influencing the field of biotechnology.
Collaborations
Throughout his career, Hansen has collaborated with renowned colleagues, including Richard H. Weisbart and Robert N. Nishimura. These partnerships have enriched his research, enabling the development of innovative solutions in the medical and biochemical fields.
Conclusion
James E. Hansen continues to be a leading figure in the realm of biotechnology, with a strong focus on enhancing the delivery of therapeutic agents. His numerous patents reflect a commitment to innovation that has the potential to change the landscape of medical treatments for complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile